The economic benefit of treating subclinical Streptococcus agalactiae mastitis in lactating cows

The economic benefits of treating lactating cows for Streptococcus agalactiae mastitis were studied at a large (689 milking cows) central California dairy. Postcure milk production of case cows (infected, treated, and cured) was compared with production of paired control cows (uninfected) and was matched for yield, days in milk, days in gestation, and parity. A simulation was used to plot expected lactation curves for mastitic cows (infected, not treated) with characteristics similar to those of each control cow, and these curves were compared with actual case-cow lactation curves. The difference in actual and expected production was used to calculate net economic benefits of treatment. Comparison of expected with actual production indicated a net benefit from treatment of $396/cow for cows treated in early lactation and $237 for cows treated in midlactation, but a net loss of $55 for cows treated in late lactation. Lactation number did not have a significant impact on economic benefits of treatment. In contrast to other studies indicating no economic benefit from treating mastitis during lactation, this study's positive results may have been attributable to the high cure rate (98%) and the subclinical form of mastitis being treated. Streptococcus agalactiae mastitis treatment during early and midlactation would appear to be an economically justifiable option for dairy managers.     

Estimation of milk production losses due to sub-clinical mastitis in dairy cattle in Costa Rica

Five dairy farms, situated on the slopes of the volcano Poás in the pre-mountain cloud forest ecological zone, Alajuela and Heredia Provinces, Costa Rica, provided data for estimation of the production losses due to sub-clinical mastitis. Within the same farm, cows with proven sub-clinical mastitis were matched with cows without signs of sub-clinical mastitis, according to breed, lactation number and days in lactation. A total of 529 cows were detected with sub-clinical mastitis, of which only 200 could be paired with control cows free of mastitis; each pair was used only once.

Crude milk production losses per cow with sub-clinical mastitis were estimated at 1.56 kg day⁻¹for daily milk yield. Milk production loss per affected quarter due to sub-clinical mastitis was estimated to be 17.6% on average. The decrease in milk production in heifers with sub-clinical mastitis did not differ significantly from the decrease in production in older cows. No significant difference in milk production loss was detected when the data were stratified on parity or the number of quarters affected.     

Microbiologic investigation of an epizootic of mastitis caused by Serratia marcescens in a dairy herd.

An epizootic of subclinical and clinical mastitis caused by Serratia marcescens was investigated in a 1,000-cow dairy farm in California. Serratia marcescens was isolated from 13 to 18% of composite milk samples obtained from lactating dairy cows. During monthly milk sampling performed during a 4-month period, S marcescens was isolated from 38.8 to 62.3% of composite milk samples obtained from cows from which S marcescens was previously isolated. Few cows infected with S marcescens had evidence of clinical mastitis. Somatic cell count value was associated with isolation of S marcescens. Cows with somatic cell counts greater than 500,000 were 5.48 times as likely to have intramammary infections with S marcescens, compared with cows with somatic cell count less than or equal to 500,000. Lactation number also was associated with S marcescens intramammary infection. After adjusting for the effect of lactation number, cows with high somatic cell count values were 2.98 times as likely to have intramammary infection with S marcescens, compared with cows with low somatic cell counts. Infection with S marcescens was independent of days in lactation, production string, and daily milk production. Eleven months after the beginning of the epizootic, S marcescens was isolated from organic bedding samples obtained from the dairy. Despite numerous attempts, other sources of S marcescens could not be identified on this dairy.     

Initial experience with the intravenous administration of colloidal carbon to cattle in relation to the incidence of mastitis

The influence was studied of intravenous application of colloid carbon to ten dairy cows of Bohemian Spotted breed in the seventh to eighth months of gravidity, as exerted on the health condition of mammary glands and on milk yield in the subsequent lactation. The cure consisted of three i. v. installations in 72-hour intervals; one dose contained 150 mg carbon in 20 ml of 20% glucose. No adverse by-effects were observed in the course of application and after it. During the subsequent lactation period (nine months) the test cows exhibited a better health condition of mammary glands if compared with the control group (ten dairy cows). In the test group no case was recorded of the clinical form of mastitis while in the control group one case of acute mastitis and two cases of chronic mastitis occurred. S. agalactiae was not isolated at all in the test group while in the control group it was isolated in two cows. S. aureus was also isolated more times (in 32 cases) in the control cows than in the test ones (in 27 cases). A higher average counts of cells in udder-quarter milk samples were found in the test group only at the onset of lactation (from the third month after calving), the average counts of cells over the whole period under study were however lower in the test group (1 380 000 per ml) than in the control group (1 234 000 per ml). The average daily milk yield per cow in the test group exceeded the average milk production in the control group in the period of study. An increase by 1.630 1 as compared with the untreated cow was observed in the average milk yield. It has been demonstrated by the results that by the intravenous instillation of colloid carbon nonspecific natural defensive mechanisms of dairy cows, mainly leucocytes, are stimulated, which enhanced the cell readiness to react to infectious process (mastitis) and overall injury of the organism (sepsis).     

Test-day somatic cell score, fat-to-protein ratio and milk yield as indicator traits for sub-clinical mastitis in dairy cattle

Test-day (TD) records of milk, fat-to-protein ratio (F:P) and somatic cell score (SCS) of first-lactation Canadian Holstein cows were analysed by a three-trait finite mixture random regression model, with the purpose of revealing hidden structures in the data owing to putative, sub-clinical mastitis. Different distributions of the data were allowed in 30 intervals of days in milk (DIM), covering the lactation from 5 to 305 days. Bayesian analysis with Gibbs sampling was used for model inferences. Estimated proportion of TD records originated from cows infected with mastitis was 0.66 in DIM from 5 to 15 and averaged 0.2 in the remaining part of lactation. Data from healthy and mastitic cows exhibited markedly different distributions, with respect to both average value and the variance, across all parts of lactation. Heterogeneity of distributions for infected cows was also apparent in different DIM intervals. Cows with mastitis were characterized by smaller milk yield (down to -5 kg) and larger F:P (up to 0.13) and SCS (up to 1.3) compared with healthy contemporaries. Differences in averages between healthy and infected cows for F:P were the most profound at the beginning of lactation, when a dairy cow suffers the strongest energy deficit and is therefore more prone to mammary infection. Residual variances for data from infected cows were substantially larger than for the other mixture components. Fat-to-protein ratio had a significant genetic component, with estimates of heritability that were larger or comparable with milk yield, and was not strongly correlated with milk and SCS on both genetic and environmental scales. Daily milk, F:P and SCS are easily available from milk-recording data for most breeding schemes in dairy cattle. Fat-to-protein ratio can potentially be a valuable addition to SCS and milk yield as an indicator trait for selection against mastitis.     

利用DHI报表对宁夏某奶牛场生产性能总体情况的分析

DHI测定是奶牛场精细化管理的工具,它不仅反映奶牛的产奶性能,饲养管理与健康水平,还能根据报表信息对奶牛场的育种与繁殖情况进行评价从而改进管理措施,利用好DHI报表信息可以提高奶牛场的技术管理水平和经济效益。本研究通过采集宁夏某奶牛场12个月的DHI报表数据,分析乳脂肪、乳蛋白、尿素氮、体细胞数、泌乳持续力等关键性指标,对该奶牛场的生产性能、经营管理、育种繁殖状况进行综合评定。结果表明：该牛场的泌乳高峰日到达较晚;牛群乳房炎在冬季发生率较高;群体尿素氮含量处于正常范围（10-18mg/dL）,对奶牛的繁殖性能影响较小;泌乳持续力较高、奶牛群体平均泌乳天数较长引起的繁殖问题较严重。针对测检和分析中发现的问题,提出了建议的改进措施。     

河北保定部分奶牛场临床型乳房炎发病情况调查研究

为探索奶牛临床型乳房炎的发病情况与泌乳量、泌乳期、季节之间的联系,以河北保定地区5个奶牛场为例进行调查研究。通过对调查结果的统计分析,结果显示：奶牛乳房炎多发生在泌乳90~150 d,泌乳天数越长发病头数越多;从产奶量来看,泌乳量越高发病牛比例越高;从发病季节来看,奶牛乳房炎在秋季发病率高,春季、夏季和冬季发病率低。     

奶牛乳腺炎的细菌学研究

在对山东7个地区14个奶牛场临床型和隐性乳腺炎调查的基础上采集234头临床乳腺炎病牛乳样、241个隐性乳腺炎乳样并分别做了细菌学检查,结果表明:泌乳期临床型乳腺炎病原菌以凝固酶阴性葡萄球菌、金黄色葡萄球菌、链球菌、酵母菌和棒状杆菌为主;干奶期临床型乳腺炎病原菌以大肠杆菌、链球菌、金黄色葡萄球菌、凝固酶阴性葡萄球菌和酵母菌为主;隐性乳腺炎病原菌以凝固酶阴性葡萄球菌、金黄色葡萄球菌链球菌、酵母菌、假单胞菌和棒状杆菌为主;厌氧菌在隐性乳腺炎、干奶期乳腺炎和干奶期乳腺炎乳样的捡出率分别为 5．82％,4．17%,10．16％;隐性乳腺炎、干奶期乳腺炎细菌的共感染率较高,与泌乳期乳腺炎病原菌的差异极显著(P<0．01),隐性乳腺炎与干奶期乳腺炎病原菌共感染率差异不显著(P >0．05)。     

过瘤胃胆碱在围产期奶牛的应用研究进展

奶牛养殖过程中,围产期被认为是最重要的时期之一,在该时期奶牛从干奶状态转为泌乳状态,生理上所受的应激造成奶牛泌乳早期采食量降低,易发生能量负平衡.此外,奶牛生产性能和繁殖性能也会降低,并常常伴有一些围产期疾病的发生,如脂肪肝、酮症、乳房炎等.胆碱能影响奶牛的生产与繁殖性能,参与奶牛的脂肪代谢,可降低脂肪肝发生率,提高免疫性能.对围产期奶牛饲喂过瘤胃保护胆碱(rumen protected choline,RPC),可改善奶牛机体代谢,增加小肠胆碱供应,进而提高奶产量、改善乳成分、缓解脂肪肝、减少围产期疾病的发生.本文综述了RPC对围产期奶牛干物质采食量、生产性能、乳成分以及健康状况的影响,旨在为围产期奶牛的养殖提供理论参考依据.     

我国规模牛场奶牛个体生鲜乳体细胞数水平及影响因素探析

本研究旨在探析我国规模奶牛场奶牛个体生鲜乳体细胞数（SCC）的水平、分布和影响因素。利用SAS9.0的GLM模型,统计分析覆盖16个省（市、区）,33个规模奶牛场,23 351头中国荷斯坦牛,从2007年至2009年连续3年的225 775条奶牛个体生鲜乳SCC检测记录。结果表明：奶牛个体生鲜乳SCC的总体均值为48×104cell/mL,标准差为117×104cell/mL,个体生鲜乳SCC波动范围较大;其中,77.9%的奶牛个体,其生鲜乳SCC小于50×104cell/mL,对群体混合样生鲜乳SCC的影响系数为0.26;11.3%的奶牛个体,其生鲜乳SCC介于50×104～100×104cell/mL之间,乳房处于隐性感染状态,对群体混合样生鲜乳SCC的影响系数为0.16;10.8%的奶牛个体,生鲜乳SCC大于100×104cell/mL,理论上乳房处于临床感染状态,对群体混合样生鲜乳SCC的影响系数为0.58。奶牛个体生鲜乳体细胞数评分（SCS）呈正态分布,与奶牛个体因素（产奶量、乳脂率、乳蛋白含量、胎次和泌乳阶段）和环境因素（泌乳月份、泌乳季节）差异极显著（P〈0.01）,与奶牛养殖区域、奶牛场差异不显著（P〉0.05）。我国规模奶牛场奶牛个体生鲜乳SCC主要在50×104cell/mL以下,依据影响参数能实现对生鲜乳SCC水平的调控。     

Between-herd prevalence of Mycoplasma bovis in bulk milk in Flanders, Belgium

Mycoplasma bovis (M. bovis) is a highly infectious pathogen of cattle causing pneumonia, polyarthritis, otitis, and less frequently, subcutaneous abscesses, abortions and meningitis. Ineffective drugs treatments, culling of infected cows and loss of milk production can lead to significant economic loss on dairy farms. The early detection of cows excreting M. bovis bacteria to prevent mastitis outbreaks is warranted. Reports suggest that the risk of M. bovis mastitis is higher in larger dairy herds. The objective of this study is to estimate the herd-level prevalence of M. bovis in Flanders, Belgium by culturing bulk tank milk samples taken from dairy farms. Three bulk tank milk samples per dairy herd were taken over four weeks, with collection intervals of two weeks. Culturing was done after pre-incubation using modified Hayflicks media to increase the chances of recovery of bacteria. For the identification of M. bovis, tDNA intergenic spacer PCR was used. In three herds (1.5%) of the 200 herds sampled, M. bovis was isolated from one of the three consecutive bulk tank milk samples. We conclude that in Flanders in 2009 at least 1.5% of the dairy herds had one or more cows excreting M. bovis in the milk. The frequent monitoring of bulk tank milk to detect the presence of M. bovis, especially in expanding herds on farms that often purchase replacement animals, should be encouraged in order to detect the presence of M. bovis and to monitor the success of control procedures following an outbreak of mycoplasmal mastitis in the herd.     

Risk factors for abomasal displacement in dairy cows.

OBJECTIVE: To determine whether various periparturient events or 305-day milk production during the previous lactation period were associated with abomasal displacement in dairy cows. DESIGN: Retrospective, case-control study. ANIMALS: 75 pairs of case and control cows from 3 university-owned and 3 commercial dairy herds. PROCEDURE: Cows with abomasal displacement were matched with control cows on the basis of herd of origin, breed, age, and calving date. Frequency of specific periparturient events during the period from 2 weeks prior to parturition to diagnosis of abomasal displacement, as well as milk production during the preceding lactation period, were compared between case and control cows. RESULTS: Multivariate analyses indicated that case cows were significantly more likely to have had retained placenta, ketosis, a stillborn calf, metritis, twins, or parturient paresis than were control cows. Dystocia, mastitis, and milk production during the previous lactation period were not associated with abomasal displacement. CLINICAL IMPLICATIONS: Results indicated that a variety of periparturient events were associated with development of abomasal displacement among dairy cows.     

Mycoplasmal mastitis in a dairy herd

In October 1985, mycoplasmas were isolated from bulk tank milk samples in a large Florida dairy (greater than 1,400 lactating cows). At that time, measures to isolate and control the spread of infection were instituted. In an initial screening test, Mycoplasma bovis was isolated from 21 of 153 milking string samples (milk from all quarters of 10 cows/string). Composite quarter milk samples from all quarters of every individual lactating cow in the herd were obtained for culture in November 1985 and December 1985. In October, 88 of 1,535 (5.7%) cows were identified as Mycoplasma-positive. An additional 31 Mycoplasma-infected cows were identified in December. The dairy elected to maintain the infected cows in a separate Mycoplasma-positive subherd, which would be milked at the end of each milking session. Seven additional Mycoplasma-positive cows were identified at initiation of lactation. All newly identified infected cows were transferred to the Mycoplasma-positive subherd. After segregation of Mycoplasma-positive cows, bulk tank milk samples obtained routinely from the main herd remained culture negative throughout the study. From February 1986 to October 1986, quarter milk samples were obtained monthly from cows in the Mycoplasma-positive subherd. Any cow that developed clinical mastitis or substantial decrease in milk production was, at the discretion of the herdsman, culled. Of the 126 cows in the subherd, 22 (17.5%) were culled for mastitis, 35 (27.8%) were culled for low production, and 9 (7.1%) were culled for other reasons. Of the remaining 60 cows, 16 (12.7% of the 126 cows) were Mycoplasma-positive on the basis of results from one or more samples obtained after February 1986.(ABSTRACT TRUNCATED AT 250 WORDS)     

Diseases and culling of Swiss dairy cows. 2. Culling and relation between diseases and milk production parameters

During three years (1982 to 1984) data were collected concerning diseases and reasons for culling in 612 dairy farms with Brown Swiss, Simmental and Black and White cattle. The frequency of culling increases in all three breeds with increasing age, from 20% at the first lactation up to 33% from the 4th lactation on. The main reasons for disposal are insufficient production, reproductive problems or udder diseases. After treatment for reproductive problems, mastitis or acetonemia, the risk for culling within the same lactation period is increased. Reproductive problems (no heat symptoms, repeat breeder, ovarian cysts) and acetonemia increase with increasing milk production in all three breeds. In cows with high 100-day-performance they are also more frequent. The occurrence of acute mastitis shows no general trend with increasing milk production or with high 100-day-performance. No systematic relationship is found between reproductive disorders or acute mastitis and persistency of milk production. On the other hand, acetonemia is somewhat more frequent in cows showing higher persistency.     

Coagulase-negative staphylococci-emerging mastitis pathogens

Coagulase-negative staphylococci (CNS) have become the most common bovine mastitis isolate in many countries and could therefore be described as emerging mastitis pathogens. The prevalence of CNS mastitis is higher in primiparous cows than in older cows. CNS are not as pathogenic as the other principal mastitis pathogens and infection mostly remains subclinical. However, CNS can cause persistent infections, which result in increased milk somatic cell count (SCC) and decreased milk quality. CNS infection can damage udder tissue and lead to decreased milk production. Staphylococcus simulans and Staphylococcus chromogenes are currently the predominant CNS species in bovine mastitis. S. chromogenes is the major CNS species affecting nulliparous and primiparous cows whereas S. simulans has been isolated more frequently from older cows. Multiparous cows generally become infected with CNS during later lactation whereas primiparous cows develop infection before or shortly after calving. CNS mastitis is not a therapeutic problem as cure rates after antimicrobial treatment are usually high. Based on current knowledge, it is difficult to determine whether CNS species behave as contagious or environmental pathogens. Control measures against contagious mastitis pathogens, such as post-milking teat disinfection, reduce CNS infections in the herd. Phenotypic methods for identification of CNS are not sufficiently reliable, and molecular methods may soon replace them. Knowledge of the CNS species involved in bovine mastitis is limited. The dairy industry would benefit from more research on the epidemiology of CNS mastitis and more reliable methods for species identification.     

The cost of summer mastitis.

The incidence of summer mastitis on 95 dairy farms in southern England was monitored in the summer of 1987. Data on the type of animal infected, the fate of the animals immediately and over the succeeding lactation, and the procedures used in treating the infections were collected for 144 cases. Twenty-five per cent of cases were attended by veterinary surgeons. Most of the animals received parenteral antibiotics and on average each received five tubes of intramammary antibiotic. The incidence of infection was highest in pregnant and calving heifers, more than 2 per cent of the animals at risk, and lowest (0.04 per cent) in calves, although more than twice as many dry cows were infected. Over half of the farms reported summer mastitis, with 36 per cent suffering more than one case. The greatest economic loss, 49 per cent of the total, was from lost milk production; and 37 per cent was from lost animal value, cull and calf losses. The average loss was 192 pounds per case. Using national incidence data from England and Wales, the cost to the UK dairy industry in 1987 was 6.22 million pounds.     

中兽药散剂治疗奶牛临床型乳房炎的研究

奶牛乳房炎严重影响奶业生产。本试验使用中兽药散剂替代抗生素对临床型奶牛乳房炎进行治疗,并对治疗过程中的奶牛乳房炎病程情况、奶牛免疫情况和牛奶品质进行观察,评估中兽药散剂的治疗效果。结果显示：中兽药散剂可有效通乳消痈;可降低牛奶中体细胞数量;可提高粒细胞含量（从2%以下提高到46.3%）;可抑制炎症,降低IL-1β、IL-6和TNF-α的含量（降低66.3%~71.0%）。得出结论：中药散剂可提高奶牛的免疫功能,治疗乳房炎。     

Efficacy of vaccination and antimicrobial treatment to eliminate chronic intramammary Staphylococcus aureus infections in dairy cattle

OBJECTIVE: To determine whether a combination of vaccination and extended intramammary antimicrobial treatment would eliminate chronic intramammary Staphylococcus aureus infections in lactating dairy cows. DESIGN: Randomized controlled clinical trial. ANIMALS: 50 dairy cows with chronic mastitis caused by S aureus. PROCEDURE: Cows were identified and paired within herd on the basis of days in milk, lactation number, milk production, and numbers of quarters infected. Treated cows (n=20) received 3 doses of a polyvalent S aureus bacterin on days 1, 15, and 21 of the study along with intramammary administration of pirlimycin in all 4 quarters once daily for 5 treatments (days 16 to 20). Control cows (n=23) received no treatment. Follow-up samples for bacteriologic culture were collected for at least 3 months after treatment to determine treatment success rates. RESULTS: Significantly more S aureus infections were eliminated from treated cows (8/20 [40%]), compared with control cows (2/23 [9%]). The proportion of infected quarters that yielded negative results throughout the follow-up period was also significantly higher in treated cows (13/28 [46%]) than in control cows (2/41 [5%]). CONCLUSIONS AND CLINICAL RELEVANCE: Results indicate that a combination of vaccination and antimicrobial treatment can be successful in eliminating some cases of chronic intramammary S aureus infections in dairy cattle. However, it is important to consider extended treatment protocols carefully because many cows are likely to remain infected with S aureus despite treatment and vaccination.     

Incidence and economics of clinical mastitis in five Holstein herds in the Czech Republic

Data on clinical mastitis (CM) collected between 1996 and 2003 on five Holstein dairy farms in the Czech Republic were analyzed. Lactational incidences of CM, averaged across farms and calculated only from cows with complete lactations, were 0.35, 0.45 and 0.57 for the first, second and third plus subsequent lactations, respectively. The mean numbers of CM cases per cow and lactation were 0.63, 0.94 and 1.22, and the incidence of CM cases per cow-year at risk were 0.68, 1.00 and 1.27 for the first, second and third plus subsequent lactations, respectively. Longitudinal analysis of CM prevalence based on daily records showed the highest proportion of infected cows in the first 10 days of lactation. The within-farm incidence of CM cases per cow per year, averaged over lactations, ranged from 0.53 to 1.56 with a mean value of 0.94 in the whole data set. Direct financial losses from CM per cow per year within farm ranged from 43.63 to 84.84 euros. They included losses from discarded milk, cost for drugs, veterinary service, herdsman's time, cost for an extra milking machine and cost for antibiotic drying of cows. The economic value of CM incidence (change in direct losses per cow per year when increasing CM incidence by one case above the average value) ranged from 58.3 to 80.1 euros per CM case per cow per year with the mean value of 62.6 euros per CM case per cow per year in the total data set. Daily prevalence rate of CM was shown to be the best among various indicators of CM susceptibility, because it accounted for the censored character of the data and for repeated cases of CM within lactations. In order to reduce the incidence of clinical mastitis for dairy cattle in the Czech Republic, we recommend that it should be included as a goal in the breeding program.     

Association between exposure to Neospora caninum and milk production in dairy cows

OBJECTIVE: To determine association between exposure to Neospora caninum and milk production in dairy cows. DESIGN: Prospective observational study. Animals: 565 Holstein cows. PROCEDURE: Cows were classified as seropositive or seronegative to N. caninum within 7 days after calving by use of a kinetic ELISA. Milk production was compared between seropositive and seronegative cows. RESULTS: On the basis of 305-day mature equivalent milk production data, seropositive cows produced less milk (2.8 lb/cow per day) than did seronegative cows. In addition, analysis of results throughout the first 300 days of lactation revealed that after adjusting for effects of lactation number, calving season, clinical mastitis, and lameness, milk weight of seropositive cows was 2.5 lb/cow per day less than that of seronegative cows. CONCLUSIONS AND CLINICAL RELEVANCE: Exposure to N. caninum was associated with a 3 to 4% decrease in milk production. A decrease in milk production of 800 lb/cow for a typical 305-day lactation represents a loss of $128/cow.